CompaniesAxentis Pharma

Axentis Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

360

By Phase

PHASE3: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00408915
Hover over trial bars to see details

Recent Trials

NCT00408915Lead Sponsor
Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion
PHASE3Completed
60 participants
Started: Jul 31, 2006
NCT00367822Lead Sponsor
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
PHASE3Completed
300 participants